BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

CytRx Corporation 

11726 San Vicente Blvd., Suite 650

Los Angeles  California  90049  U.S.A.
Phone: 310-826-5648 Fax: 310-826-6139


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Dr. Anita J. Chawla Joins CytRx Corporation (CYTR) Board Of Directors To Add Additional Drug Commercialization Expertise In Oncology 3/11/2015 7:39:09 AM
CytRx Corporation (CYTR) Reports 2014 Financial Results 3/10/2015 10:19:01 AM
CytRx Corporation (CYTR) To Present At The Cowen and Company 35th Annual Health Care Conference 2/25/2015 10:22:48 AM
CytRx Corporation (CYTR) To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference On February 9, 2015 In New York City 2/2/2015 11:51:32 AM
CytRx Corporation (CYTR) Announces Overall Survival Results From Its Global Phase 2b Clinical Trial Of Aldoxorubicin In Soft Tissue Sarcoma 1/22/2015 8:12:56 AM
FDA Removes Partial Clinical Hold on CytRx Corporation (CYTR)'s Brain Cancer Trials 1/20/2015 6:41:01 AM
CytRx Corporation (CYTR) Announces Positive Interim Phase 2 Aldoxorubicin Results As A Treatment For HIV-Related Kaposi's Sarcoma (KS) 1/8/2015 8:22:01 AM
CytRx Corporation (CYTR) Announces Positive Interim Phase 2 Aldoxorubicin Results In Glioblastoma Multiforme (Brain Cancer) 1/6/2015 6:10:25 AM
CytRx Corporation (CYTR)'s Brain Cancer Drug Shows Promise in Mid-Stage Study 1/6/2015 6:09:44 AM
CytRx Corporation (CYTR) To Present At The Oppenheimer 25th Annual Healthcare Conference 12/4/2014 3:22:43 PM
12345678910...